Invention Application
- Patent Title: ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES
-
Application No.: US17742221Application Date: 2022-05-11
-
Publication No.: US20220275397A1Publication Date: 2022-09-01
- Inventor: Virginia AMMENDOLA , Stefania CAPONE , Stefano COLLOCA , Antonella FOLGORI , Rossella MERONE
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Priority: GB1620968.6 20161209
- Main IPC: C12N15/86
- IPC: C12N15/86 ; A61K39/21 ; C07K14/005 ; A61K39/12 ; A61P31/18 ; A61P31/14
Abstract:
The present invention relates to isolated polynucleotide and polypeptide sequences derived from novel chimpanzee adenovirus ChAd157, as well as to recombinant polynucleotides, vectors, adenoviruses, cells and compositions comprising said polynucleotide and polypeptide sequences.
Public/Granted literature
- US11795478B2 Adenovirus polynucleotides and polypeptides Public/Granted day:2023-10-24
Information query
IPC分类:
